Ümit Elif Gülsüm, Kuloğlu Figen, Demir Ahmet Muzaffer
Trakya University Faculty of Medicine, Department of Hematology, Edirne, Turkey Phone: +90 284 235 76 41-2687 E-mail:
Turk J Haematol. 2017 Mar 1;34(1):89-92. doi: 10.4274/tjh.2016.0108. Epub 2016 Aug 16.
Vancomycin-resistant enterococci (VRE) are common pathogens of hospital-acquired infection. Long hospitalization periods, use of broad-spectrum antibiotics, and immunosuppression are major risks for VRE colonization. We aimed to evaluate patients' characteristics and factors that may contribute to VRE colonization.
Data of 66 patients with colonization and 112 patients without colonization who were hospitalized in the hematology clinic were collected. Hematological malignancies, preexisting gastrointestinal complaints, the presence of hypogammaglobulinemia at the time of diagnosis, complications like neutropenic enterocolitis (NEC), and Eastern Cooperative Oncology Group (ECOG) and Karnofsky performance statuses were recorded.
Ages of the patients ranged between 19 and 95 years (mean: 55.99). Karnofsky and ECOG scores were statistically related to VRE colonization (p<0.000 and p<0.000), though only the Karnofsky score was significant based on logistic regression analysis. Almost all patients with acute leukemia (45 patients) had been on antibiotics (piperacillin-tazobactam, ceftazidime, and meropenem), while no patients with myelodysplastic syndrome, myeloma, or benign diseases and 2 patients with lymphoma and 1 with chronic myeloid leukemia were on antibiotics. Median time for colonization regardless of antibiotic use and diagnosis was 4.5 days (range: 3-11 days). In the VRE-colonized group, 40.9% of patients had NEC development, while in the non-colonized group, only 1.7% had NEC development. In the VRE-colonized group 46 patients (69.7%) and in the non-colonized group 27 patients (24.1%) had hypogammaglobulinemia at diagnosis; among these patients, 23 patients in the VRE-colonized group (50%) had a B-cell malignancy (lymphoma, myeloma, or chronic lymphocytic leukemia).
Besides already anticipated diseases like leukemia, B-cell malignancies are also at high risk for colonization. This proclivity may be attributed to lack of gastrointestinal IgA due to hypogammaglobulinemia. Prolonged hospitalization (>7 days) may also be accepted as a risk factor, independent of diagnosis or antibiotic use. Performance status is also an important factor for colonization, which may be related to poorer hygiene and increased external help.
耐万古霉素肠球菌(VRE)是医院获得性感染的常见病原体。住院时间长、使用广谱抗生素和免疫抑制是VRE定植的主要风险因素。我们旨在评估患者的特征以及可能导致VRE定植的因素。
收集了血液科住院的66例有定植的患者和112例无定植的患者的数据。记录血液系统恶性肿瘤、既往胃肠道疾病、诊断时低丙种球蛋白血症的存在情况、中性粒细胞减少性小肠结肠炎(NEC)等并发症以及东部肿瘤协作组(ECOG)和卡氏评分。
患者年龄在19至95岁之间(平均:55.99岁)。卡氏评分和ECOG评分与VRE定植在统计学上相关(p<0.000和p<0.000),不过基于逻辑回归分析只有卡氏评分具有显著性。几乎所有急性白血病患者(45例)都使用过抗生素(哌拉西林 - 他唑巴坦、头孢他啶和美罗培南),而骨髓增生异常综合征、骨髓瘤或良性疾病患者以及2例淋巴瘤患者和1例慢性粒细胞白血病患者均未使用抗生素。无论是否使用抗生素及诊断情况如何,定植的中位时间为4.5天(范围:3 - 11天)。在VRE定植组中,40.9%的患者发生了NEC,而在未定植组中,只有1.7%的患者发生了NEC。在VRE定植组中,46例患者(69.7%)在诊断时有低丙种球蛋白血症,在未定植组中,27例患者(24.1%)在诊断时有低丙种球蛋白血症;在这些患者中,VRE定植组的23例患者(50%)患有B细胞恶性肿瘤(淋巴瘤、骨髓瘤或慢性淋巴细胞白血病)。
除了白血病等已预料到的疾病外,B细胞恶性肿瘤患者也有很高的定植风险。这种倾向可能归因于低丙种球蛋白血症导致胃肠道IgA缺乏。延长住院时间(>7天)也可被视为一个风险因素,与诊断或抗生素使用无关。身体状况也是定植的一个重要因素,这可能与较差的卫生条件和更多的外部帮助有关。